BIO

Bio-Rad Laboratories Inc
$379.63+$4.72+1.26%Price as of Nov 4, 2026, 4:15 PM ET

Key stats

Market cap
10.2B
Open
—
Day range
—
52-week range
$236.73 – $396.23
Volume
233K
Avg volume
222K

Earnings

Q3 FY26Upcoming
Expected$2.25
Q2 FY26
Actual$13.85
Q1 FY26
Actual$-19.55
Q4 FY25
Actual$26.65

Next earnings call Feb 11, 2027

About

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Employees
7,450
Headquarters
Hercules, CA